TAF13 Antibody, FITC conjugated
-
中文名稱：TAF13兔多克隆抗體, FITC偶聯
-
貨號：CSB-PA614893LC01HU
-
規格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) TAF13 Polyclonal antibody
-
Uniprot No.：
-
基因名：TAF13
-
別名：MGC22425 antibody; TAF(II)18 antibody; taf13 antibody; TAF13 RNA polymerase II; TATA box binding protein (TBP) associated factor; 18kDa antibody; TAF13_HUMAN antibody; TAF2K antibody; TAFII 18 antibody; TAFII-18 antibody; TAFII18 antibody; Transcription initiation factor TFIID 18 kDa subunit antibody; Transcription initiation factor TFIID subunit 13 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Transcription initiation factor TFIID subunit 13 protein (1-124AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：FITC
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Component of the DNA-binding general RNA polymerase II transcription factor IID complex (TFIID). TFIID plays a critical role in the regulation of gene transcription in eukaryotic cells.
-
基因功能參考文獻：
- two homozygous missense are associated with autosomal-recessive intellectual disability and microcephaly PMID: 28257693
-
相關疾病：Mental retardation, autosomal recessive 60 (MRT60)
-
亞細胞定位：Nucleus.
-
蛋白家族：TAF13 family
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
